Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT) Director Sells $754,000.00 in Stock

Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) Director Jennifer Straumins sold 50,000 shares of the stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $15.08, for a total value of $754,000.00. Following the transaction, the director now owns 1,034,589 shares in the company, valued at approximately $15,601,602.12. This trade represents a 4.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Jennifer Straumins also recently made the following trade(s):

• On Monday, June 16th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The stock was sold at an average price of $16.23, for a total value of $1,623,000.00.
• On Thursday, June 5th, Jennifer Straumins sold 100,000 shares of Calumet Specialty Products Partners stock. The stock was sold at an average price of $13.17, for a total value of $1,317,000.00.

Calumet Specialty Products Partners Stock Performance

Shares of CLMT opened at $16.86 on Tuesday. Calumet Specialty Products Partners, L.P. has a 52-week low of $7.68 and a 52-week high of $25.29. The business's fifty day moving average is $12.25 and its 200-day moving average is $15.23. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of -6.11 and a beta of 0.91.

Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last issued its quarterly earnings data on Friday, May 9th. The oil and gas company reported ($1.03) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.62). The company had revenue of $993.90 million during the quarter, compared to analyst estimates of $899.62 million. The firm's revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.51) EPS. As a group, research analysts forecast that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.

Analyst Ratings Changes

CLMT has been the topic of a number of recent research reports. UBS Group upgraded Calumet Specialty Products Partners from a "sell" rating to a "neutral" rating and lowered their price objective for the stock from $15.00 to $12.00 in a research note on Monday, March 17th. Bank of America initiated coverage on Calumet Specialty Products Partners in a research note on Tuesday, May 13th. They set a "buy" rating and a $15.00 price objective on the stock. Wells Fargo & Company lowered their price objective on Calumet Specialty Products Partners from $23.00 to $21.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. The Goldman Sachs Group lowered their price objective on Calumet Specialty Products Partners from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. Finally, TD Cowen lowered Calumet Specialty Products Partners from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $26.00 to $16.00 in a research note on Tuesday, March 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $18.50.

Calumet Specialty Products Partners Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.